|
231 |
Research waste in diagnostic trials: a methods review evaluating the reporting of test-treatment interventions
Enthalten in BMC medical research methodology Bd. 17, 24.2.2017, Nr. 1, date:12.2017: 1-13
|
|
|
|
232 |
Response to letter to editor: ‘Comment on Arch et al., Trials. 2016;17:517’
Enthalten in Trials Bd. 18, 26.5.2017, Nr. 1, date:12.2017: 1-4
|
|
|
|
233 |
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Enthalten in Journal of neuroinflammation Bd. 14, 3.1.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
234 |
Review and publication of protocol submissions to Trials – what have we learned in 10 years?
Enthalten in Trials Bd. 18, 16.12.2016, Nr. 1, date:12.2017: 1-5
|
|
|
|
235 |
Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic
Enthalten in Advances in therapy Bd. 35, 21.12.2017, Nr. 1, date:1.2018: 12-30
|
|
|
|
236 |
Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions
Enthalten in Pharmaceutical medicine Bd. 31, 18.7.2017, Nr. 4, date:8.2017: 245-255
|
|
|
|
237 |
Routinely collected data for randomized trials: promises, barriers, and implications
Enthalten in Trials Bd. 19, 11.1.2018, Nr. 1, date:12.2018: 1-9
|
|
|
|
238 |
S2O – A software tool for integrating research data from general purpose statistic software into electronic data capture systems
Enthalten in BMC medical informatics and decision making Bd. 17, 7.1.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
239 |
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
Enthalten in BMC psychiatry Bd. 17, 8.2.2017, Nr. 1, date:12.2017: 1-28
|
|
|
|
240 |
SESOTHO trial (“Switch Either near Suppression Or THOusand”) – switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa
Enthalten in BMC infectious diseases Bd. 18, 12.2.2018, Nr. 1, date:12.2018: 1-9
|
|
Administration
